文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

多巴胺药效动力学:新见解。

Dopamine Pharmacodynamics: New Insights.

机构信息

Geriatric Clinic Unit, Geriatric-Rehabilitation Department, University Hospital, 43126 Parma, Italy.

Cognitive and Motor Center, Medicine and Geriatric-Rehabilitation Department of Parma, University-Hospital of Parma, 43126 Parma, Italy.

出版信息

Int J Mol Sci. 2024 May 13;25(10):5293. doi: 10.3390/ijms25105293.


DOI:10.3390/ijms25105293
PMID:38791331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11121567/
Abstract

Dopamine is a key neurotransmitter involved in physiological processes such as motor control, motivation, reward, cognitive function, and maternal and reproductive behaviors. Therefore, dysfunctions of the dopaminergic system are related to a plethora of human diseases. Dopamine, via different circuitries implicated in compulsive behavior, reward, and habit formation, also represents a key player in substance use disorder and the formation and perpetuation of mechanisms leading to addiction. Here, we propose dopamine as a model not only of neurotransmission but also of neuromodulation capable of modifying neuronal architecture. Abuse of substances like methamphetamine, cocaine, and alcohol and their consumption over time can induce changes in neuronal activities. These modifications lead to synaptic plasticity and finally to morphological and functional changes, starting from maladaptive neuro-modulation and ending in neurodegeneration.

摘要

多巴胺是一种关键的神经递质,参与生理过程,如运动控制、动机、奖励、认知功能以及母婴和生殖行为。因此,多巴胺能系统的功能障碍与许多人类疾病有关。多巴胺通过涉及强迫行为、奖励和习惯形成的不同回路,也是物质使用障碍以及导致成瘾的机制的形成和持续的关键因素。在这里,我们提出多巴胺不仅是一种神经递质模型,也是一种能够修饰神经元结构的神经调质。滥用像冰毒、可卡因和酒精这样的物质以及随着时间的推移消费这些物质会导致神经元活动的变化。这些变化导致突触可塑性,最终导致形态和功能的变化,从适应不良的神经调节开始,最终导致神经退行性变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c012/11121567/9f2ff46fff99/ijms-25-05293-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c012/11121567/205fce28d3c9/ijms-25-05293-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c012/11121567/ecbce3fd33d6/ijms-25-05293-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c012/11121567/9f2ff46fff99/ijms-25-05293-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c012/11121567/205fce28d3c9/ijms-25-05293-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c012/11121567/ecbce3fd33d6/ijms-25-05293-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c012/11121567/9f2ff46fff99/ijms-25-05293-g003.jpg

相似文献

[1]
Dopamine Pharmacodynamics: New Insights.

Int J Mol Sci. 2024-5-13

[2]
Synaptic plasticity and addiction: learning mechanisms gone awry.

Neuropharmacology. 2011-1-28

[3]
Targeting VGLUT2 in Mature Dopamine Neurons Decreases Mesoaccumbal Glutamatergic Transmission and Identifies a Role for Glutamate Co-release in Synaptic Plasticity by Increasing Baseline AMPA/NMDA Ratio.

Front Neural Circuits. 2018-8-29

[4]
Dopamine: The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control.

Cells. 2021-3-26

[5]
Effects of dopamine and glutamate on synaptic plasticity: a computational modeling approach for drug abuse as comorbidity in mood disorders.

Pharmacopsychiatry. 2011-5-4

[6]
Roles of dopamine and glutamate co-release in the nucleus accumbens in mediating the actions of drugs of abuse.

FEBS J. 2021-3

[7]
GIRK Channel Plasticity and Implications for Drug Addiction.

Int Rev Neurobiol. 2015

[8]
A Novel and Selective Dopamine Transporter Inhibitor, -MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions.

Biomolecules. 2022-6-24

[9]
Psychostimulants, madness, memory... and RGS proteins?

Neuromolecular Med. 2005

[10]
A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use.

J Psychopharmacol. 1998

引用本文的文献

[1]
Candidate Key Proteins of Tinnitus in the Auditory and Motor Systems of the Thalamus.

Int J Mol Sci. 2025-6-17

[2]
The Dark Side of "Smart Drugs": Cognitive Enhancement vs. Clinical Concerns.

Toxics. 2025-3-26

[3]
Design, Synthesis, and Biological Evaluation of Novel Hydroxytyrosol Derivatives as Protectors for Vascular Endothelium Against Lipid Overload.

Drug Des Devel Ther. 2025-4-1

[4]
Epigallocatechin -3- gallate mitigates diazinon neurotoxicity via suppression of pro-inflammatory genes and upregulation of antioxidant pathways.

BMC Neurosci. 2025-3-10

[5]
Healthy Behavior for Preventing Cognitive Disability in Older Persons.

Int J Environ Res Public Health. 2025-2-12

[6]
Role of ruscogenin extracted from Radix Ophiopogon Japonicus in antagonizing 5-hydroxytryptamine and dopamine receptors through computational screening.

PLoS One. 2024

[7]
The Role of Dopamine Neurotransmitters in Neurological Diseases: New Sight.

Int J Mol Sci. 2024-7-9

本文引用的文献

[1]
Trial of Lixisenatide in Early Parkinson's Disease.

N Engl J Med. 2024-4-4

[2]
Alcohol and the dopamine system.

Int Rev Neurobiol. 2024

[3]
Dopamine D1-Receptor Organization Contributes to Functional Brain Architecture.

J Neurosci. 2024-3-13

[4]
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Lancet Neurol. 2024-1

[5]
Endogenous opioid system modulates conditioned cocaine reward in a sex-dependent manner.

Addict Biol. 2023-10

[6]
Biphasic patterns of age-related differences in dopamine D1 receptors across the adult lifespan.

Cell Rep. 2023-9-26

[7]
Cell and circuit complexity of the external globus pallidus.

Nat Neurosci. 2023-7

[8]
Ethanol inhibits dopamine uptake via organic cation transporter 3: Implications for ethanol and cocaine co-abuse.

Mol Psychiatry. 2023-7

[9]
Clinical Evaluation of Sleep Disorders in Parkinson's Disease.

Brain Sci. 2023-4-3

[10]
Substance abuse and neurodegenerative diseases: focus on ferroptosis.

Arch Toxicol. 2023-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索